186 related articles for article (PubMed ID: 8757996)
1. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
Segouffin C; Gruffat H; Sergeant A
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
3. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.
Furnari FB; Zacny V; Quinlivan EB; Kenney S; Pagano JS
J Virol; 1994 Mar; 68(3):1827-36. PubMed ID: 8107245
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
5. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
Adamson AL; Kenney SC
Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
Sun CC; Thorley-Lawson DA
J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
[TBL] [Abstract][Full Text] [Related]
9. Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.
Balan N; Osborn K; Sinclair AJ
J Gen Virol; 2016 Mar; 97(3):725-732. PubMed ID: 26653871
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required.
Giot JF; Mikaelian I; Buisson M; Manet E; Joab I; Nicolas JC; Sergeant A
Nucleic Acids Res; 1991 Mar; 19(6):1251-8. PubMed ID: 1851554
[TBL] [Abstract][Full Text] [Related]
11. The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding.
Hicks MR; Al-Mehairi SS; Sinclair AJ
J Virol; 2003 Jul; 77(14):8173-7. PubMed ID: 12829857
[TBL] [Abstract][Full Text] [Related]
12. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW
Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.
Sista ND; Barry C; Sampson K; Pagano J
Nucleic Acids Res; 1995 May; 23(10):1729-36. PubMed ID: 7784177
[TBL] [Abstract][Full Text] [Related]
17. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
[TBL] [Abstract][Full Text] [Related]
18. The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.
Zerby D; Chen CJ; Poon E; Lee D; Shiekhattar R; Lieberman PM
Mol Cell Biol; 1999 Mar; 19(3):1617-26. PubMed ID: 10022850
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
20. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
